publication date: May. 24, 2019

In Brief

Mullighan named deputy director of St. Jude

Charles G. Mullighan was named deputy director of St. Jude Children’s Research Hospital Comprehensive Cancer Center.

In this position, Mullighan will help guide precision medicine, preclinical, and other strategic research initiatives for the center.

His research focuses on using integrated genomic, epigenomic, and experimental approaches to understand acute lymphoblastic leukemia and related disorders. He has led studies that have defined the inherited and somatic genetic alterations in ALL. The findings have led to genomically informed diagnostic approaches and multiple clinical trials testing precision medicine approaches.

Mullighan joined the St. Jude Department of Pathology faculty in 2008. He currently serves as co-leader of the Cancer Center’s Hematological Malignancies program. Mullighan holds the William E. Evans Endowed Chair and served as medical director of the St. Jude Biorepository. He joined the hospital in 2004.

Mullighan received a 2017 NCI R35 Outstanding Investigator Award and the 2016 American Society of Hematology William Dameshek Prize. In 2016, he was the first recipient of the St. Baldrick’s Foundation Robert J. Arceci Innovation Award.

In 2018, Mullighan established the Public Resource of Patient-derived and Expanded Leukemias initiative. The initiative makes available to the scientific community one of the world’s largest collections of clinically and genetically characterized xenograft leukemia samples from children and adults.


Dimopoulos and Mateos to receive achievement awards from IMF

The International Myeloma Foundation, at a ceremony in Amsterdam June 11, will honor two multiple myeloma specialists whose work has improved the lives of patients.

The IMF will present the Robert A. Kyle Lifetime Achievement Award to Meletios A. Dimopoulos, and the Brian G.M. … Continue reading Mullighan named deputy director of St. Jude

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.